Our top pick for
Building a portfolio
M.D.C. Holdings, Inc is a residential construction business based in the US. M-D-CHoldings shares (MDC) are listed on the NYSE and all prices are listed in US Dollars. M-D-CHoldings employs 1,773 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$20.32 - $62.21|
|50-day moving average||$58.67|
|200-day moving average||$52.44|
|Wall St. target price||$64.12|
|Dividend yield||$1.352 (2.26%)|
|Earnings per share (TTM)||$5.17|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing M-D-CHoldings stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of M-D-CHoldings's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
M-D-CHoldings's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 12x. In other words, M-D-CHoldings shares trade at around 12x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
M-D-CHoldings's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.04. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into M-D-CHoldings's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
M-D-CHoldings's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $485.7 million.
The EBITDA is a measure of a M-D-CHoldings's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3.9 billion|
|Operating margin TTM||11.75%|
|Gross profit TTM||$861.7 million|
|Return on assets TTM||7.96%|
|Return on equity TTM||18.84%|
|Market capitalisation||$4.2 billion|
TTM: trailing 12 months
There are currently 1.7 million M-D-CHoldings shares held short by investors – that's known as M-D-CHoldings's "short interest". This figure is 12% down from 1.9 million last month.
There are a few different ways that this level of interest in shorting M-D-CHoldings shares can be evaluated.
M-D-CHoldings's "short interest ratio" (SIR) is the quantity of M-D-CHoldings shares currently shorted divided by the average quantity of M-D-CHoldings shares traded daily (recently around 659381.2749004). M-D-CHoldings's SIR currently stands at 2.51. In other words for every 100,000 M-D-CHoldings shares traded daily on the market, roughly 2510 shares are currently held short.
However M-D-CHoldings's short interest can also be evaluated against the total number of M-D-CHoldings shares, or, against the total number of tradable M-D-CHoldings shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case M-D-CHoldings's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 M-D-CHoldings shares in existence, roughly 20 shares are currently held short) or 0.0361% of the tradable shares (for every 100,000 tradable M-D-CHoldings shares, roughly 36 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against M-D-CHoldings.
Find out more about how you can short M-D-CHoldings stock.
Dividend payout ratio: 26.31% of net profits
Recently M-D-CHoldings has paid out, on average, around 26.31% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.27% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), M-D-CHoldings shareholders could enjoy a 2.27% return on their shares, in the form of dividend payments. In M-D-CHoldings's case, that would currently equate to about $1.352 per share.
While M-D-CHoldings's payout ratio might seem fairly standard, it's worth remembering that M-D-CHoldings may be investing much of the rest of its net profits in future growth.
M-D-CHoldings's most recent dividend payout was on 23 February 2021. The latest dividend was paid out to all shareholders who bought their shares by 8 February 2021 (the "ex-dividend date").
M-D-CHoldings's shares were split on a 108:100 basis on 1 March 2021. So if you had owned 100 shares the day before before the split, the next day you'd have owned 108 shares. This wouldn't directly have changed the overall worth of your M-D-CHoldings shares – just the quantity. However, indirectly, the new 7.4% lower share price could have impacted the market appetite for M-D-CHoldings shares which in turn could have impacted M-D-CHoldings's share price.
Over the last 12 months, M-D-CHoldings's shares have ranged in value from as little as $20.3199 up to $62.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while M-D-CHoldings's is 1.4832. This would suggest that M-D-CHoldings's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
M. D. C. Holdings, Inc. , through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company conducts its homebuilding operations in Arizona, California, Nevada, Washington, Oregon, Colorado, Utah, Virginia, Maryland, and Florida.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.